CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-06 | Invus Public Equities, L.P. Director | Purchase | +95,079 | $12.58 | $1.2M | 2,668,059 |
| 2018-06-05 | Invus Public Equities, L.P. Director | Purchase | +173,121 | $12.45 | $2.2M | 2,572,980 |
| 2018-06-04 | Invus Public Equities, L.P. Director | Purchase | +121,803 | $12.24 | $1.5M | 2,399,859 |
| 2018-06-01 | Invus Public Equities, L.P. Director | Purchase | +147,339 | $12.22 | $1.8M | 2,278,056 |
| 2018-05-31 | Invus Public Equities, L.P. Director | Purchase | +147,339 | $11.62 | $1.7M | 2,130,717 |
| 2018-05-30 | Invus Public Equities, L.P. Director | Purchase | +147,339 | $10.32 | $1.5M | 1,983,378 |
| 2018-05-29 | Invus Public Equities, L.P. Director | Purchase | +147,339 | $9.84 | $1.5M | 1,836,039 |
| 2018-05-25 | Invus Public Equities, L.P. Director | Purchase | +138,700 | $9.62 | $1.3M | 1,688,700 |
| 2018-05-23 | Santini Alexander A EVP and CCO | Purchase | +745 | $9.78 | $7K | 5,297 |
| 2018-04-27 | Swain Judith L Director | Grant or award | +2,564 | 12,902 | ||
| 2018-04-27 | Swain Judith L Director | Grant or award · Stock Option (Right to Buy) | +2,857 | 2,857 | ||
| 2018-04-27 | SOBECKI CHRISTOPHER J Director | Grant or award | +2,564 | 13,044 | ||
| 2018-04-27 | SOBECKI CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +2,857 | 2,857 | ||
| 2018-04-27 | Palantoni Frank Director | Grant or award | +2,564 | 12,902 | ||
| 2018-04-27 | Palantoni Frank Director | Grant or award · Stock Option (Right to Buy) | +2,857 | 2,857 | ||
| 2018-04-27 | NIES ALAN S Director | Grant or award | +2,564 | 13,616 | ||
| 2018-04-27 | NIES ALAN S Director | Grant or award · Stock Option (Right to Buy) | +2,857 | 2,857 | ||
| 2018-04-27 | LEFKOWITZ ROBERT J MD Director | Grant or award | +2,564 | 12,902 | ||
| 2018-04-27 | LEFKOWITZ ROBERT J MD Director | Grant or award · Stock Option (Right to Buy) | +2,857 | 2,857 | ||
| 2018-04-27 | DEBBANE RAYMOND Director | Grant or award | +2,564 | 12,902 |
Page 50 of 51 · 1,001 trades